The phrase "a middle dose of" is correct and usable in written English.
It can be used when discussing medication, treatment, or any context where dosage is relevant, indicating a dose that is neither too low nor too high.
Example: "The doctor recommended a middle dose of the medication to ensure optimal effectiveness without causing side effects."
Alternatives: "an intermediate dose of" or "a moderate dose of".
It said patients should start on a middle dose of the drug and should consider a high dose only if they do not lose 3 percent of their body weight after 12 weeks.
For another optimized ''stress test'', a middle dose of GPC3 CAR-T cells (3 × 106 cells/mouse) was injected, the growth of HuH-7 tumors were suppressed significantly as well as the high dose (Fig. 2H).
For another optimized ''stress test'', a middle dose of GPC3 CAR-T cells was injected, although G3-28BBz and G3-28z-41BBL cells cells displayed a similar capability to inhibit the growth of tumor, the latter was significantly more effective in prolonging the survival of the tumor-bearing mice.
The doses were selected to provide a low dose of 50 ppm which is non-carcinogenic and does not cause an increase in liver weight, a middle dose of 500 ppm which causes an increase in liver weight but is not carcinogenic and high dose of 1000 ppm which is carcinogenic and causes an increase in liver weight.
As per OECD [ 16] guideline, after the safety evaluation of the plant, 1/10th of the maximum dose (2000 mg/kg) was considered as a middle dose, half and double of the middle dose were taken as the low and the high doses, respectively.
Figure 3 presents a series of endocrine and metabolic indices evaluated in UM-HET3 mice exposed to rapamycin at 4 months of age, at the middle dose of 14 ppm, in parallel to a cohort placed on a 40% DR diet at the same age.
In late-stage clinical trials, patients on the middle dose of Qsymia lost an average of 8.4 percent of their weight after one year.
But after 210 days (a full zebrafish lifetime) of exposure to the middle dose of 5.0 ng/L ethynylestradiol, the second generation of fish showed reduced fertility.
After 16 weeks, the women in all the groups reported a somewhat better sex life, although the increase was statistically meaningful only for the group that received the middle dose of testosterone.
The middle dose of 3.2 μg/kg/min NE was selected as the reference standard (NE control).
The middle dose of rapamycin (14 ppm) is the same as that used for an earlier, independent cohort (Miller et al., 2011).
